# Effect of N-Acetylcysteine on Autologous Fat Graft Survival

> **NCT02788292** · PHASE4 · WITHDRAWN · sponsor: **Nova Scotia Health Authority**

## Conditions studied

- Adipose Tissue Atrophy
- Deformity of Reconstructed Breast
- Graft Loss

## Interventions

- **DRUG:** Acetylcysteine

## Key facts

- **NCT ID:** NCT02788292
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08-15
- **Primary completion:** 2020-11-16
- **Final completion:** 2020-11-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unable to hire research staff
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02788292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02788292, "Effect of N-Acetylcysteine on Autologous Fat Graft Survival". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02788292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*